Based on DART filings, revenue for the first nine months of 2026 was KRW 197 million, down 43.3% from the same period a year earlier. Operating loss for the same period was KRW 5.39 billion and net loss was KRW 5.61 billion, with losses widening versus the prior-year period.
According to the audit report, 2025 revenue was about KRW 794.5 million, up roughly 94.3% from 2024, while the 2025 operating loss widened to KRW 14.7 billion from KRW 11.7 billion in 2024. The revenue increase is mainly attributed to health insurance reimbursement for CART BP pro.
Press reports based on the securities registration statement said first-half 2026 revenue was about KRW 5.0 billion, with overseas sales at 52% of the total. Press and filing figures may follow different aggregation bases, so they should be read with care.
Shares closed on the first trading day on September 4, 2026 at KRW 23,500, up 135.0% from the offer price, and hit the daily upper limit on the next trading day.
Market data from early October 2026 showed a price of KRW 18,020, and the price as of 06:55 KST on November 18, 2026 was KRW 6,940, down 2.80% from the previous close. Market capitalization is KRW 130.2 billion and trading value is KRW 700 million. As of September 2026, major shareholders were the Korea Development Bank (6.53%) and IMM (6.44%).